IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.350
+0.021 (6.35%)
Nov 21, 2024, 12:48 PM EST - Market open
IN8bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 13.08 | 13.51 | 14.46 | 7.31 | 3.18 | 2.71 | |
| Research & Development | 17.89 | 16.83 | 14.06 | 7.35 | 5.38 | 2.36 | |
| Operating Expenses | 31.3 | 30.34 | 28.52 | 14.65 | 8.56 | 5.07 | |
| Operating Income | -31.3 | -30.34 | -28.52 | -14.65 | -8.56 | -5.07 | |
| Other Non Operating Income (Expenses) | 0.33 | 0.33 | - | - | - | - | |
| EBT Excluding Unusual Items | -30.81 | -30.01 | -28.52 | -14.65 | -8.56 | -5.07 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.07 | |
| Pretax Income | -31.88 | -30.01 | -28.52 | -14.65 | -8.56 | -5.13 | |
| Net Income | -31.88 | -30.01 | -28.52 | -14.65 | -8.56 | -5.13 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.78 | 0.78 | |
| Net Income to Common | -31.88 | -30.01 | -28.52 | -14.65 | -10.34 | -5.91 | |
| Shares Outstanding (Basic) | 43 | 30 | 21 | 10 | 3 | 3 | |
| Shares Outstanding (Diluted) | 43 | 30 | 21 | 10 | 3 | 3 | |
| Shares Change (YoY) | 56.99% | 42.43% | 110.32% | 191.59% | 7.24% | 1.65% | |
| EPS (Basic) | -0.74 | -1.00 | -1.36 | -1.47 | -3.02 | -1.85 | |
| EPS (Diluted) | -0.74 | -1.00 | -1.36 | -1.47 | -3.02 | -1.85 | |
| Free Cash Flow | -25.2 | -23.94 | -27.83 | -13.82 | -7.13 | -5.13 | |
| Free Cash Flow Per Share | -0.59 | -0.80 | -1.33 | -1.39 | -2.09 | -1.61 | |
| EBITDA | -29.5 | -28.5 | -27.91 | -14.03 | -8.47 | -4.97 | |
| D&A For EBITDA | 1.8 | 1.83 | 0.61 | 0.63 | 0.09 | 0.1 | |
| EBIT | -31.3 | -30.34 | -28.52 | -14.65 | -8.56 | -5.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.